31st December 2007
Following the completion of the reverse takeover the details of which were announced on 12 December 2007, the ordinary shares of OASG (formerly called Kanyon Plc) have this morning been admitted to trading on AIM with the ticker symbol OXA. OASG has developed technology that enables the modification of the surface properties of a range of materials in order to increase and diversify their applications and functionalities. The technology is based on research that commenced over ten years ago at the Department of Chemistry at the University of Oxford and can be applied to inert surfaces in order to modify their surface properties. The Subscription and Acquisition each became unconditional upon Admission.
Admission Statistics
| Number of Existing Ordinary Shares (following consolidation on a 1 for 10 basis) | 88,384,131 |
| Number of Consideration Shares issued | 77,539,907 |
| Number of Subscription Shares issued | 12,000,000 |
| Subscription Price | 25 pence |
| Number of New Ordinary Shares in issue on Admission | 177,924,038 |
| Gross proceeds of the Subscription available to the Company | £3.0 million |
| Market capitalisation immediately following Admission at the Subscription Price | £44.50 million |
| TIDM Symbol | OXA |
| Percentage of Enlarged Issued Share capital represented by: | |
| Existing Ordinary Shares | 49.68 % |
| Consideration Shares | 43.58 % |
| Subscription Shares | 6.74 % |
Zimmerman Adams International Limited is acting as the Nominated Adviser to the Company and Hichens, Harrison & Co. Plc as the Broker to the Company.
Definitions used in this announcement will have the same meanings, unless the context requires otherwise, as those used in the AIM admission document of the Company dated 12 December 2007.
Marcelo Bravo, CEO, commented
“We are delighted that OASG has successfully listed on AIM today. We believe that Admission to AIM and the funds available to the company will provide an ideal platform for future growth of the Company. OASG has a strong team and we look forward to the future development of the Company “
OASG Strategy
The strategy is to become an advanced materials and technology solutions company with business units across a range of markets. The board of OASG have identified three priority markets for the application of the technology, which are:
The board’s focus will be on both exploiting the technology in the markets described above as well as developing further applications of the Technology in areas such as photovoltaics through Solar Labs plc (another subsidiary in the group), biomedical materials and specialised filtration media.
The board plans to establish three distinct business units in the above markets within OASG and to recruit commercial directors to run and develop these business units. In addition, it is the intention of the Continuing Board to continue to seek to establish opportunities in-house or through external collaborations in markets such as photovoltaics and membranes for separation and filtration processes.
It is expected that OASG will initially generate development fees from these partnerships before ultimately licensing its Technology for commercial use. The board believe such partnering arrangements will enable OAS to leverage the relevant partners expertise in particular sectors as well as their market access resulting in lower risk for OAS and a faster route to market.
OASG does not, however, intend to manufacture chemicals or materials on a large scale itself. Instead, its strategy will be to enter into co-development arrangements with leading companies with applications in high value markets as well as leading speciality chemical companies. Where appropriate, OASG will enter into contract manufacturing arrangements.
To support the business and technology development needs, it is the board’s intention to establish a base research and design capability with both an organic chemistry synthesis team and several focused application development teams in electronics, speciality industrials and life sciences.
OASG will also explore opportunities to establish various external collaborations with academics both at the University of Oxford and elsewhere to develop further Intellectual Property Rights in these areas. The Enlarged Group will use the experience of the Continuing Board in the development of collaborations with academic research institutions to commercialise intellectual property.
OASG Technology
OASG’ technology is a coating technology that exploits a reactive type of molecule, known as a carbene. The technology controls the reactivity of the molecule so that it can be applied to inert surfaces in order to modify their surface properties. The technology is a platform technology that permits the modification of a range of materials to deliver a range of functionalities, thus creating new opportunities in advanced materials.
The coatings are applied to surfaces in a multi-step process. Firstly, the coating is rolled, dipped, painted or sprayed onto the surface and, secondly, the coating is then cured by heat or UV resulting in a chemically attached coating. OAS is working to further develop the technology to enable it to deliver precise patterns of surface functionality and to deliver more than one functionality on a substrate.
The technology enables a range of materials to be modified including:
Principal applications of the technology
OAS’ initial strategy has been to explore a range of industries and, since incorporation in September 2006, it has had contact with over sixty companies throughout the world. Following on from this, OAS has signed confidentiality agreements with approximately thirty companies to proceed to advanced discussions regarding the technology. This has resulted in OAS signing agreements with seven companies for co-development projects which are currently revenue-earning. Moreover, OAS is discussing a number of proposals with various potential customers and conducting several “preliminary proof of concept” evaluations with a view to embarking on development programmes in the near future.
OAS will initially focus on three areas of application following its testing of the technology in potential markets it has investigated during the first year of its commercial operations. They are not, however, in the board’s opinion, representative of the breadth and scope of the applicability of the technology.
As OAS scales its business development activities, it is the board’s intention that there will be a growth in the number of projects looking at more functionalities and substrate materials in differing areas of application. The board has identified the following technological areas which they intend to initially focus OAS activities in exploiting:
1. Tailored Wetting Properties
The wettability (hydrophillicity, hydrophobicity, oleophillicity and oleophobicity) of a material or the degree to which a material can be wetted by a liquid is an important function for OAS’ customers in a number of applications currently being developed by OAS.
The Technology can be used to tailor the wettability of a range of materials including low surface energy substrates such as fluoropolymers. OAS is currently developing its Technology in this area as follows:
2. Adhesion Promotion
The technology can be used to promote chemical adhesion acting as a primer for existing adhesives, bonding agents or radiation cured coatings as well as facilitating the incorporation of particles at the interface between materials to increase adhesion.
OAS is currently using the technology to develop coatings:
3. Biocidal Activity
OAS has designed a coating using its technology which permits the release of hydrogen peroxide, an environmentally benign broad spectrum biocide which can be regenerated by treating with a solution of hydrogen peroxide. The board believes this application of the technology could be used in consumer and healthcare markets as well as in water and air purification.
| Oxford Advanced Surfaces Group Plc | |
| Marcelo Bravo Michael Bretherton |
Tel: +44 (0) 1865 854 807 Tel: +44 (0) 20 7099 7266 |
| Zimmerman Adams International Limited | |
| David Galan/Jonathan Evans | Tel: +44 (0) 20 7060 1760 |